Journal article
A randomized phase II/III study comparing stereotactic body radiotherapy (SBRT) versus conventional palliative radiotherapy (CRT) for patients with spinal metastases (NCT02512965).
Abstract
TPS10129
Background: Innovative radiotherapy technology and modern imaging capabilities enable the use of Stereotactic Body Radiotherapy (SBRT) to treat patients with spinal metastases to optimize tumour control and palliation compared to standard conventional radiotherapy. No randomized clinical trial evidence exists directly comparing the two treatment strategies. Methods: SC.24 is a Canadian Cancer Trials Group randomized …
Authors
Sahgal A; Myrehaug S; Dennis K; Liu M; Chow E; Wong R; Butler JB; Greenspoon JN; Fehlings MG; Maralani P
Journal
Journal of Clinical Oncology, Vol. 35, No. 15_suppl, pp. tps10129–tps10129
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2017
DOI
10.1200/jco.2017.35.15_suppl.tps10129
ISSN
0732-183X